LONDON–(BUSINESS WIRE)–#Biotechnology–The global conjunctivitis therapeutics market is poised to grow by USD 451.33 million during 2019-2023, progressing at a CAGR of nearly 3% during the forecast period. Request Free Sample Pages
Read the 121-page research report with TOC on “Conjunctivitis Therapeutics Market Analysis Report by Type (Allergic conjunctivitis, Bacterial conjunctivitis, and Viral conjunctivitis), by Geography (North America, Europe, Asia, and ROW), and Segment Forecasts, 2019 – 2023.”
https://www.technavio.com/report/global-conjunctivitis-therapeutics-market-industry-analysis
The market is driven by the increasing instances of allergy. In addition, the rising number of people engaging in self-medication is anticipated to positively impact the growth of the conjunctivitis therapeutics market.
There is a significant increase in the prevalence of allergies across the globe. The rising incidence of pollen allergy and dust mite allergy increases the risk for allergic conjunctivitis. Additionally, the rising pollution and the increasing carbon dioxide levels are also contributing to the increase in the prevalence of allergic conjunctivitis. Moreover, other allergies such as hay fever and asthma also lead to allergic conjunctivitis. Thus, the growing number of allergy cases will drive the need for conjunctivitis therapeutics, leading to the market growth.
Increasing access to information has led to greater awareness of diseases, which in turn, has led to the growing trend of self-diagnosis and self-medication. This is positively influencing the purchase volume of various OCT drugs. Thus, with the easy availability and administration of various OTC drugs, the global conjunctivitis therapeutics market will witness positive growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Conjunctivitis Therapeutics Market Companies:
Akorn, Incorporated
Akorn, Incorporated operates its business under various segments such as prescription pharmaceuticals and consumer health. Some of the products offered by the company are AzaSite and COSOPT PF.
ALLERGAN
ALLERGAN operates its business across three segments, which include US specialized therapeutics, US general medicine, and international. The company’s key offerings include ACULAR, BLEPHAMIDE, POLYTRIM, and ZYMAXID.
Bausch Health
Bausch Health has business operations under various segments, namely Bausch + Lomb/international, branded Rx, and U.S. diversified products. Some of the products offered by the company are Alrex, BEPREVE, Besivance, and ZYLET.
Novartis AG
Novartis AG operates its business under three segments, which include Innovative medicines, Sandoz, and Alcon. The company’s key offerings include NAPHCON-A eye drops, MOXEZA, PATANOL, and PATADAY.
Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. operates its businesses under the following segments: pharmaceuticals, medical devices, and others. The company’s key offerings in the conjunctivitis therapeutics market include Alegysal and Oftaquix.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Conjunctivitis Therapeutics Type Outlook (Revenue, USD Million, 2019 – 2023)
- Allergic conjunctivitis
- Bacterial conjunctivitis
- Viral conjunctivitis
Conjunctivitis Therapeutics Regional Outlook (Revenue, USD Million, 2019 – 2023)
- Asia
- Europe
- ROW
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on HealthCare include:
Eye Infections Therapeutics Market – Global Eye Infections Therapeutics Market by type (conjunctivitis, keratitis, blepharitis, and other eye infections) and geography (Asia, Europe, North America, and ROW).
Eye Allergy Therapeutics Market – Global Eye Allergy Therapeutics Market by products (antihistamines, mast cell stabilizers, corticosteroids, immunomodulators, and others) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
media@technavio.com.